Posted On: 01/12/2015 9:46:08 AM
Post# of 30066
Not unless someone gives the company an offer they can not refuse for Lympro prior to Q2. But nothing is is set in stone as we still have no uplist for AMBS.
How is AMBS paying for this? Maybe 300-500 million shares that were just authorized?
Regardless, a very interesting turn of events. We shall see how this all unfolds.
How is AMBS paying for this? Maybe 300-500 million shares that were just authorized?
Regardless, a very interesting turn of events. We shall see how this all unfolds.
(0)
(0)
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
